Search research articles
Contact Us
Filters
Showing results (11-20 of 175) with videos related to
Page
of 18
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
April 9, 2004
Adiponectin in anorexia nervosa and bulimia nervosa
Tetsuya Tagami, Noriko Satoh, Takeshi Usui, et al.
Frontiers in Pharmacology
|
March 1, 2021
Taxifolin: A Potential Therapeutic Agent for Cerebral Amyloid Angiopathy
Satoshi Saito, Masashi Tanaka, Noriko Satoh-Asahara, et al.
Cardiovascular Diabetology
|
August 14, 2015
Association between metabolic syndrome and multiple lesions of intracranial atherothrombotic stroke: a hospital-based study
Kazuhiko Kotani, Noriko Satoh-Asahara, Takuya Nakakuki, et al.
Endocrine Journal
|
October 4, 2023
Differences in metabolic characteristics between Metabolically Healthy Obesity (MHO) and Metabolically Unhealthy Obesity (MUO) in weight reduction therapy
Shiori Kawai, Hajime Yamakage, Kazuhiko Kotani, et al.
Cells
|
June 5, 2019
Oxytocin Suppresses Inflammatory Responses Induced by Lipopolysaccharide through Inhibition of the eIF-2-ATF4 Pathway in Mouse Microglia
Takayuki Inoue, Hajime Yamakage, Masashi Tanaka, et al.
Scientific Reports
|
September 8, 2022
Analysis of time-dependent changes in the FIB4 index in patients with obesity receiving weight reduction therapy
Shiori Kawai, Hajime Yamakage, Kazuhiko Kotani, et al.
Journal of Diabetes Investigation
|
November 14, 2019
Effects of dapagliflozin on the serum levels of fibroblast growth factor 21 and myokines and muscle mass in Japanese patients with type 2 diabetes: A randomized, controlled trial
Hajime Yamakage, Masashi Tanaka, Takayuki Inoue, et al.
Diabetes Care
|
June 27, 2013
Response to Comment on: Satoh-Asahara et al. Highly purified eicosapentaenoic acid increases interleukin-10 levels of peripheral blood monocytes in obese patients with dyslipidemia. Diabetes Care 2012;35:2631-2639
Noriko Satoh-Asahara, Akira Shimatsu, Hiromichi Wada, et al.
Journal of Biochemistry
|
November 8, 2005
Red blood cells highly express type I platelet-activating factor-acetylhydrolase (PAF-AH) which consists of the alpha1/alpha2 complex
Ken Karasawa, Mariko Shirakura, Ayako Harada, et al.
Diagnostic Cytopathology
|
July 8, 2010
Cytopathologic features of secondary peripheral ameloblastic carcinoma: a case report
Shuichi Fujita, Masanobu Anami, Noriko Satoh, et al.
Page
of 18
Search research articles
Search
Showing results (11-20 of 175) with videos related to
Sort By:
Page
of 18
The Journal of Clinical Endocrinology and Metabolism
|
April 9, 2004
Adiponectin in anorexia nervosa and bulimia nervosa
Tetsuya Tagami, Noriko Satoh, Takeshi Usui, et al.
Frontiers in Pharmacology
|
March 1, 2021
Taxifolin: A Potential Therapeutic Agent for Cerebral Amyloid Angiopathy
Satoshi Saito, Masashi Tanaka, Noriko Satoh-Asahara, et al.
Cardiovascular Diabetology
|
August 14, 2015
Association between metabolic syndrome and multiple lesions of intracranial atherothrombotic stroke: a hospital-based study
Kazuhiko Kotani, Noriko Satoh-Asahara, Takuya Nakakuki, et al.
Endocrine Journal
|
October 4, 2023
Differences in metabolic characteristics between Metabolically Healthy Obesity (MHO) and Metabolically Unhealthy Obesity (MUO) in weight reduction therapy
Shiori Kawai, Hajime Yamakage, Kazuhiko Kotani, et al.
Cells
|
June 5, 2019
Oxytocin Suppresses Inflammatory Responses Induced by Lipopolysaccharide through Inhibition of the eIF-2-ATF4 Pathway in Mouse Microglia
Takayuki Inoue, Hajime Yamakage, Masashi Tanaka, et al.
Scientific Reports
|
September 8, 2022
Analysis of time-dependent changes in the FIB4 index in patients with obesity receiving weight reduction therapy
Shiori Kawai, Hajime Yamakage, Kazuhiko Kotani, et al.
Journal of Diabetes Investigation
|
November 14, 2019
Effects of dapagliflozin on the serum levels of fibroblast growth factor 21 and myokines and muscle mass in Japanese patients with type 2 diabetes: A randomized, controlled trial
Hajime Yamakage, Masashi Tanaka, Takayuki Inoue, et al.
Diabetes Care
|
June 27, 2013
Response to Comment on: Satoh-Asahara et al. Highly purified eicosapentaenoic acid increases interleukin-10 levels of peripheral blood monocytes in obese patients with dyslipidemia. Diabetes Care 2012;35:2631-2639
Noriko Satoh-Asahara, Akira Shimatsu, Hiromichi Wada, et al.
Journal of Biochemistry
|
November 8, 2005
Red blood cells highly express type I platelet-activating factor-acetylhydrolase (PAF-AH) which consists of the alpha1/alpha2 complex
Ken Karasawa, Mariko Shirakura, Ayako Harada, et al.
Diagnostic Cytopathology
|
July 8, 2010
Cytopathologic features of secondary peripheral ameloblastic carcinoma: a case report
Shuichi Fujita, Masanobu Anami, Noriko Satoh, et al.
Page
of 18